Irma Bagdoniene։ Why Intensive Prevention is the Most Rational Strategy in Preventive Cardiology
Irma Bagdoniene, Cardiologist Specializing in Prevention & Lipidology, shared on LinkedIn about a recent article by Jennifer G. Robinson et al, published in Journal of the American Heart Association:
”Is early, intensive prevention ‘aggressive’? It’s not. On World Logic Day, it just makes sense.
I often tell my patients:
The human body follows simple logic.
In preventive cardiology, clinical inertia is a common barrier. But the evidence to avoid delays is overwhelming. This is the basis of our ‘strike early, strike strong’ strategy:
- The logic of time: Atherosclerosis results from cumulative exposure. It’s the total LDL burden over decades—the “mg-years”—that defines risk. The sooner we act, the more years we protect.
- The logic of causality: LDL cholesterol is a proven causal factor in ASCVD. Mendelian randomization studies and large clinical trials consistently confirm this. Lowering LDL prevents downstream events.
- The logic of measurement: We cannot manage what we don’t detect. Risk scores alone fall short. Advanced assessments like CACS, CCTA, Lp(a), and ApoB provide clear evidence of subclinical disease—calling for early intervention.
The conclusion is simple. The evidence and tools are ready. Early application is the most rational approach to stopping heart attacks before they occur.
Prevention is not aggressive—it is the sensible choice.
On World Logic Day (Jan 14), proclaimed by UNESCO, a reminder:
Good medicine is often just good logic!”
Title: Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Authors: Jennifer G. Robinson, Kevin Jon Williams, Samuel Gidding, Jan Borén, Ira Tabas, Edward A. Fisher, Chris Packard, Michael Pencina, Zahi A. Fayad, Venkatesh Mani, Kerry Anne Rye, Børge G. Nordestgaard, Anne Tybjærg-Hansen, Pamela S. Douglas, Stephen J. Nicholls, Neha Pagidipati, Allan Sniderman
Read the Full Article on Journal of the American Heart Association․
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?